Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
23-26 March, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
23-26 March, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Digital content

04 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/04/3180843/0/en/Vaxcyte-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update-Including-Final-Data-from-Positive-VAX-24-Infant-Phase-2-Dose-Finding-Study.html

03 Oct 2025
// FIERCE PHARMA
https://www.fiercepharma.com/manufacturing/vaxcyte-strikes-1b-deal-fill-finish-space-thermo-fishers-nc-production-facility

30 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/30/3158591/0/en/Vaxcyte-to-Establish-Fill-Finish-Manufacturing-in-North-Carolina-as-Key-Element-of-Long-Term-United-States-Commercial-Supply-Strategy-Representing-Up-to-1-Billion-in-Manufacturing-.html

06 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/06/3128686/0/en/Vaxcyte-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Update-Highlighting-Key-Clinical-and-Regulatory-Progress-for-VAX-31-a-Potential-Best-in-Class-Pneumococc.html

07 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/07/3076529/0/en/Vaxcyte-Reports-First-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

01 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/01/3072338/0/en/Vaxcyte-Appoints-Dr-Olivier-Brandicourt-to-Board-of-Directors.html
ABOUT THIS PAGE